Target in Sight: A Comprehensive Review of Hydroxychloroquine-Induced Bull's Eye Maculopathy
- PMID: 39371107
- PMCID: PMC11452169
- DOI: 10.1007/s40135-024-00321-6
Target in Sight: A Comprehensive Review of Hydroxychloroquine-Induced Bull's Eye Maculopathy
Abstract
Purpose of review: We review the latest screening and diagnostic techniques, and the most recent recommendations on the management of hydroxychloroquine retinopathy.
Recent findings: Hydroxychloroquine (HCQ) has been shown to cause retinal toxicity in a dose-dependent fashion. Early diagnosis is critical as the resultant retinopathy is not reversible. New imaging modalities, such as adaptive optics (AO), microperimetry, and retro-mode imaging, may show promise in the timely diagnosis of HCQ retinopathy.
Summary: Automated visual fields and spectral-domain optical coherence tomography (SD-OCT) are the primary tests used in routine screening for HCQ retinopathy, but fundus autofluorescence (FAF) and multifocal electroretinogram (mfERG) have also been shown to be useful. A baseline ophthalmologic examination is recommended in all patients beginning long-term hydroxychloroquine therapy within the first year of starting therapy. Automated visual fields and SD-OCT should be included during this baseline exam in patients with pre-existing macular conditions. Afterwards, annual screening can be deferred for the first 5 years of HCQ treatment unless the patient has a major risk factor.
Keywords: Bull’s Eye maculopathy; Bull’s Eye retinopathy; Hydroxychloroquine retinopathy; Hydroxychloroquine toxicity; Plaquenil retinopathy; Plaquenil toxicity.
Conflict of interest statement
Competing interests Not applicable
Figures
References
-
- Gabourel JD (1963) Effects of hydroxychloroquine on the growth of mammalian cells in vitro. J Pharmacol Exp Ther 141:122–130 - PubMed
-
- Alarcón GS, McGwin G, Bertoli AM, Fessler BJ, Calvo-Alén J, Bastian HM, Vilá LM, Reveille JD, LUMINA Study Group (2007) Effect of hydroxychloroquine on the survival of patients with systemic lupus erythematosus: data from LUMINA, a multiethnic US cohort (LUMINA L). Ann Rheum Dis 66:1168–1172 - PMC - PubMed
-
- Fanouriakis A, Kostopoulou M, Alunno A, et al. (2019) 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus. Ann Rheum Dis 78:736–745 - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials